Who
Melvin Sharoky
Director
Company insider
Files Form 4 as: Director, Insmed; Director, Par Pharmaceutical Companies; Director, Andrx Corp /de/.
In numbers
- Trades disclosed
- 197
- Buys
- 14
- Sells
- 13
- Bought
- $3.2M
- Sold
- $12.3M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 28 Feb 2006
- Last trade
- 17 Aug 2026
- Last filed
- 19 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Aug 2026filed 19 Aug 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $638K5,000 at $127.53 | filing |
| 17 Aug 2026filed 19 Aug 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $638K5,000 at $127.53 | filing |
| 13 May 2026filed 15 May 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code A | —3,305 | filing |
| 13 May 2026filed 15 May 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code A | —3,305 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code G | —100 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code G | —100 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code G | —1,072 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code G | —243 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code G | —243 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code G | —243 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code G | —243 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code G | —1,072 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code G | —243 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code G | —243 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code G | —243 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code G | —243 at $0.00 | filing |
| 5 Dec 2025filed 9 Dec 2025 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $4.1M20,000 at $205.01 | filing |
| 12 Sep 2025filed 15 Sep 2025 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $1.5M10,000 at $145.39 | filing |
| 11 Sep 2025filed 15 Sep 2025 | INSM InsmedBiotechnology | SEC FORM 4 Code G | —2,000 at $0.00 | filing |
| 11 Sep 2025filed 15 Sep 2025 | INSM InsmedBiotechnology | SEC FORM 4 Code G | —159 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.